Tilray | TRLY - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acasti Pharma USD -2.88M 564K 2026-03
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Aurora Cannabis CAD 11.41M 12.99M 2026-03
Avita Medical AUD -11.64M 12.13M 2025-12
Canopy Growth CAD -157.96M 95.71M 2026-03
Cronos Group USD 18.14M 30.52M 2026-03
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Moderna USD -1.33B 535M 2026-03
Organigram Holdings CAD -921K 40.8M 2026-03
Organon & Co USD 183M 30M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -247.3M 95.7M 2026-03
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zealand Pharma A/S -394M 12.5M 2026-03